Plasma Glucose Reduction With the SGLT2 Inhibitor, Dapagliflozin, Improves Insulin Sensitivity and Insulin Secretion in T2DM

被引：0
|
作者：
Abdul-Ghani, Muhammad A.
Merovci, Aurora
Solis-Herrera, Carolina
Eldor, Roy
Tripathy, Divjit
Daniele, Giuseppe
Defronzo, Ralph A.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
242-OR
引用
收藏
页码：A62 / A62
页数：1
相关论文
共 50 条
  • [1] Effect of Dapagliflozin With and Without Acipimox on Insulin Sensitivity and Insulin Secretion in T2DM Males
    Merovci, Aurora
    Abdul-Ghani, Muhammad
    Mari, Andrea
    Solis-Herrera, Carolina
    Xiong, Juan
    Daniele, Giuseppe
    Tripathy, Devjit
    DeFronzo, Ralph A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (03): : 1249 - 1256
  • [2] Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin
    Mudaliar, Sunder
    Henry, Robert R.
    Boden, Guenther
    Smith, Steven
    Chalamandaris, Alexandros-Georgios
    Duchesne, Dominique
    Iqbal, Nayyar
    List, James
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2014, 16 (03) : 137 - 144
  • [3] SGLT2 blockers in T2DM
    Barranco, Caroline
    [J]. NATURE REVIEWS CARDIOLOGY, 2018, 15 (05) : 255 - 255
  • [4] The Effect of SGLT2 Inhibitor Dapagliflozin on Serum Levels of Apelin in T2DM Patients with Heart Failure
    Berezin, Alexander A.
    Fushtey, Ivan M.
    Berezin, Alexander E.
    [J]. BIOMEDICINES, 2022, 10 (07)
  • [5] SGLT2 blockers in T2DM
    Caroline Barranco
    [J]. Nature Reviews Cardiology, 2018, 15 : 255 - 255
  • [6] Insulin Secretion and Sensitivity Pattern Is Different in patients With T2DM Only or Patients With T2DM and NAFLD
    Pan, Xiaoyu
    Liu, Qing
    Song, Kexiu
    Chai, Shangyu
    Li, Fei
    Huang, Yueye
    Bhavna, Bhavna
    Jhummon, Navina Priya
    Qu, Shen
    [J]. DIABETES, 2013, 62 : A492 - A492
  • [7] Survey to Specify SGLT2 Inhibitor Choice in T2DM Management
    Ghosal, Samit
    Joshi, Radhika M.
    Iyer, Rahul N.
    Adsule, Samir M.
    [J]. CLINICAL DIABETOLOGY, 2022, 11 (05): : 326 - 332
  • [8] The Menin Inhibitor Ziftomenib Induces Insulin Production and Improves Insulin Sensitivity in a Rat Model of Type 2 Diabetes Mellitus (T2DM)
    Mccloskey, Asako
    Liu, Yahu A.
    Wang, Xingjuan
    Burrows, Francis
    [J]. DIABETES, 2024, 73
  • [9] Renal outcomes with sodium glucose cotransporter 2 (SGLT2) inhibitor, dapagliflozin, in obese insulin-resistant model
    Jaikumkao, Krit
    Pongchaidecha, Anchalee
    Chueakula, Nuttawud
    Thongnak, Laongdao
    Wanchai, Keerati
    Chatsudthipong, Varanuj
    Chattipakorn, Nipon
    Lungkaphin, Anusorn
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (06): : 2021 - 2033
  • [10] SGLT2 inhibitors in people with and without T2DM
    Khunti, Kamlesh
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2021, 17 (02) : 75 - 76
12345